Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 83.8B | 78.9B | 76.5B | 74.6B |
Cost of revenue | 34.3B | 33.2B | 32.1B | 30.7B |
Gross profit | 49.5B | 45.8B | 44.4B | 43.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 20.0B | 19.0B | 19.1B | 18.0B |
Operating income | 13.5B | 12.1B | 11.8B | 12.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 1.2B | 1.2B | 1.1B | 1.1B |
Other income expense | — | — | — | — |
Pretax income | 11.4B | 12.0B | 12.1B | 13.2B |
Tax provision | 4.3B | 3.5B | 3.9B | 4.1B |
Net income | 9.0B | 8.5B | 8.2B | 9.2B |
Basic EPS | — | 14.6 | 14 | 15.7 |
Diluted EPS | — | 14.6 | 14 | 15.7 |
Basic average shares | — | 580.9M | 583.8M | 585.9M |
Diluted average shares | — | 580.9M | 583.8M | 585.9M |
EBITDA | 18.9B | 17.4B | 17.0B | 18.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | 6.5M | 2.4M | 4.3M | 10M |
Preferred stock dividends | 0 | 0 | 0 | 0 |